Citations

Clear

9 citation(s) found for "Smith, Adam".

Mapping the journey of patients and care partners living with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: developing a framework for improvements in care
Rutherford, Holly A. , Rush, Beth , Smith, Adam R. , Sullivan, Erin, Martínez‐Rubio, Clarissa, Toumadj, Ali, Piana, Roberta La , Cassandro, Cynthia, Rush, Beth K , Sullivan, Erin

Mayo Clinic

Neurodegenerative Disease Management | October 4, 2024 | Volume: 14 | Issue: 5 | Pages: 161-172

10.1080/17582024.2024.2404378 | PMID 39363647 Get It

Genetic Risk of Second Primary Cancer in Breast Cancer Survivors: The Multiethnic Cohort Study
Chen, Fei , Park, Sungshim L. , Wan, Peggy , Hart, Steven N. , Yadav, Siddhartha , Couch, Fergus J. , Haiman, Christopher A. , Chen, Chen , Hart, Steven N , Hu, Chunling , Yadav, Siddhartha , Couch, Fergus J. , Haiman, Christopher A , Chen, C , Chen, Fei , Wilkens, Lynne R. , Hu, Chunling , Conti, David V. , Smith, Adam J. de

Mayo Clinic

Cancer Research | July 14, 2022 | Volume: 82 | Issue: 18 | Pages: 3201-3208

10.1158/0008-5472.can-21-4461 | PMID 35834270 Get It

Abstract Women who have had breast cancer in the past are at increased risk of developing a second primary cancer (SPC), including second primary breast cancer (SPBC) or a second primary non-breast cancer (SPNBC). In the Multiethnic Cohort (MEC) Study, we conducted a prospective cohort analysis in 3,223 female breast cancer survivors from five racial/ethnic populations (White, African American, Japanese American, Latino, and Native Hawaiian) to assess the association of rare pathogenic variants (PV) in 37 known cancer predisposition genes with risk of SPC. A total of 719 (22.3%) women developed SPC, of which, 323 (10.0%) were SPBC. Germline PVs in BRCA1 (HR, 2.28; 95% CI, 1.11–4.65) and ERCC2 (HR, 3.51; 95% CI, 1.29–9.54) were significantly enriched in women with SPC. In the subtype analysis for SPBC, a significant association of ERCC2 PVs (HR, 5.09; 95% CI, 1.58–16.4) and a suggestive association of BRCA2 PVs (HR, 2.24; 95% CI, 0.91–5.55) were observed. There was also a higher risk of SPNBC in carriers of BRCA1 PVs (HR, 2.98; 95% CI, 1.21–7.36). These results provide evidence that germline PVs in BRCA1, BRCA2, and ERCC2 contribute to the development of SPC in breast cancer survivors. These findings also suggest that compromised DNA repair mechanisms could be a predisposition factor for SPC in patients with breast cancer, supporting the need for closer monitoring of SPC in women carrying PVs in these genes. Significance: This multiethnic study links germline pathogenic variants in BRCA1, BRCA2, and ERCC2 to the development of second primary cancer in breast cancer survivors, providing biological insights and biomarkers to guide patient monitoring.
Guiding the global evolution of cytogenetic testing for hematologic malignancies
Akkari, Yassmine, Baughn, Linda B. , Dubuc, Adrian M. , Smith, Adam C. , Mallo, Mar , Cin, Paola Dal , Díez‐Campelo, María , Gallego, Marta S., Granada, Isabel , Haase, D., Schlegelberger, Brigitte , Slavutsky, Irma , Mecucci, Cristina , Levine, Ross L. , Hasserjian, Robert P. , Solé, Françesc , Levy, Brynn , Xu, Xinjie , Akkari, Yassmine M N , Dal Cin, Paola , Granada Font, Isabel , Baughn, Linda B , Solé, Francesc , Diez-Campelo, Maria , Haase, Detlef

Mayo Clinic

Blood | February 15, 2022 | Volume: 139 | Issue: 15 | Pages: 2273-2284

10.1182/blood.2021014309 | PMID 35167654 Get It

Abstract Cytogenetics has long represented a critical component in the clinical evaluation of hematologic malignancies. Chromosome banding studies provide a simultaneous snapshot of genome-wide copy number and structural variation, which have been shown to drive tumorigenesis, define diseases, and guide treatment. Technological innovations in sequencing have ushered in our present-day clinical genomics era. With recent publications highlighting novel sequencing technologies as alternatives to conventional cytogenetic approaches, we, an international consortium of laboratory geneticists, pathologists, and oncologists, describe herein the advantages and limitations of both conventional chromosome banding and novel sequencing technologies and share our considerations on crucial next steps to implement these novel technologies in the global clinical setting for a more accurate cytogenetic evaluation, which may provide improved diagnosis and treatment management. Considering the clinical, logistic, technical, and financial implications, we provide points to consider for the global evolution of cytogenetic testing.
Missense SNP rs3731249 Explains the CDKN2A Association with Childhood ALL and Shows Risk Allele Selection in Tumors with Somatic CDKN2A Alterations
Hansen, Helen M. , Barcellos, Lisa F. , Chokkalingam, Anand P. , Jenkins, Robert B. , Wrensch, Margaret , Wiemels, Joseph L. , Smith, Adam J. de , Walsh, Kyle M. , Wiencke, John K. , Metayer, Catherine

Mayo Clinic

Blood | October 10, 2019 | Volume: 124 | Issue: 21 | Pages: 129-129

10.1182/blood.v124.21.129.129 Get It

Abstract Little is known about the interaction between constitutive and somatic genetic variation in carcinogenesis. Genome-wide association studies (GWAS) of childhood acute lymphoblastic leukemia (ALL) have identified 6 genetic associations, including the single nucleotide polymorphism (SNP) rs3731217, located between the CDKN2A and CDKN2B genes. Somatic deletions of this chromosome 9p21.3 region are common in cancer, and occur in ~30% of childhood ALL. We replicated the rs3731217 association with childhood ALL in Hispanics (P = 0.021) via a GWAS of 323 childhood ALL cases and 454 controls, using the Illumina OmniExpress SNP array. SNP imputation analysis across chromosome 9p21.3 revealed a stronger association at SNP rs3731249 (P = 6.4x10-4; OR = 2.77), a low-frequency missense variant in exon 2 (p.Ala148Thr) of CDKN2A (MAFcontrols = 2.1%). These associations were replicated in an additional 378 ALL cases and 536 controls using Taqman assays, where the missense variant again had a greater magnitude of effect (Prs3731249 = 6.5x10-3; OR rs3731249 = 2.00 versus Prs3731217 = 0.029; OR rs3731217= 1.38). We assessed the effect of rs3731249 on risk of other cancers with known chr9p21.3 GWAS associations, but observed no association between this variant and either adult glioblastoma or melanoma risk, suggesting an ALL-specific role for rs3731249. We hypothesized that cases heterozygous for rs3731249 may show allelic imbalance, with preferential loss of the wildtype (WT) allele when hemizygous chr9p21.3 deletions occur in leukemic cells. To test this, we developed a novel method termed “SMART-ddPCR” (Somatic Mutation Allelic Ratio Test using Droplet Digital PCR). Concentration of risk and WT alleles was measured by ddPCR using the rs3731249 Taqman assay in diagnostic bone marrow (i.e. tumor) DNA from 35 known heterozygotes. Allelic imbalance due to somatic CDKN2A alterations was identified in 17 cases, of which 14 had a higher risk:WT allele ratio (P = 0.006, 1-sided binomial significance test), thus demonstrating preferential loss of WT rs3731249 and retention of the missense allele. Subclonal heterogeneity in CDKN2A copy number was also evident, suggesting that CDKN2A alterations are secondary events in leukemogenesis. Preferential allelic imbalance towards the rs3731249 risk allele in ALL tumor DNA provides strong evidence of an important role for this missense variant in leukemogenesis. We show, for the first time, a direct relationship between constitutive and somatic genetic variants underlying ALL development, suggesting that such constitutive variants can provide an additional substrate for selection during tumor evolution. Disclosures No relevant conflicts of interest to declare.
A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution
Walsh, Kyle M. , Smith, Adam J. de , Hansen, Helen M. , Smirnov, Ivan, Gonseth, Semira , Endicott, Alyson , Xiao, Jianqiao, Rice, Terri, Fu, Cecilia, McCoy, Lucie , Eckel‐Passow, Jeanette E. , Jenkins, Robert B. , Wrensch, Margaret , Metayer, Catherine , Wiemels, Joseph L. , Lachance, Daniel Honore , Wiencke, John K. , Ma, Xiaomei

Mayo Clinic

Cancer Research | November 2, 2015 | Volume: 75 | Issue: 22 | Pages: 4884-4894

10.1158/0008-5472.can-15-1105 | PMID 26527286 Get It

Abstract Genome-wide association studies (GWAS) have identified SNPs in six genes that are associated with childhood acute lymphoblastic leukemia (ALL). A lead SNP was found to occur on chromosome 9p21.3, a region that is deleted in 30% of childhood ALLs, suggesting the presence of causal polymorphisms linked to ALL risk. We used SNP genotyping and imputation-based fine-mapping of a multiethnic ALL case–control population (Ncases = 1,464, Ncontrols = 3,279) to identify variants of large effect within 9p21.3. We identified a CDKN2A missense variant (rs3731249) with 2% allele frequency in controls that confers three-fold increased risk of ALL in children of European ancestry (OR, 2.99; P = 1.51 × 10−9) and Hispanic children (OR, 2.77; P = 3.78 × 10−4). Moreover, of 17 patients whose tumors displayed allelic imbalance at CDKN2A, 14 preferentially retained the risk allele and lost the protective allele (PBinomial = 0.006), suggesting that the risk allele provides a selective advantage during tumor growth. Notably, the CDKN2A variant was not significantly associated with melanoma, glioblastoma, or pancreatic cancer risk, implying that this polymorphism specifically confers ALL risk but not general cancer risk. Taken together, our findings demonstrate that coding polymorphisms of large effect can underlie GWAS “hits” and that inherited polymorphisms may undergo directional selection during clonal expansion of tumors. Cancer Res; 75(22); 4884–94. ©2015 AACR.
Patient Perceptions of Open and Arthroscopic Shoulder Surgery
Sperling, John W. , Cofield, Robert H. , Barnes, Sunni A., Smith, Adam

Mayo Clinic

Arthroscopy | April 5, 2007 | Volume: 23 | Issue: 4 | Pages: 361-366

10.1016/j.arthro.2006.12.006 | PMID 17418327 Get It

Purpose There has been a significant increase in surgeon as well as patient interest in arthroscopic treatment of shoulder pathology. We hypothesize that patients have a strong preference for arthroscopic shoulder surgery. Currently, there are no data in the literature reporting on how people perceive open versus arthroscopic shoulder surgery. Methods Prospectively, a total of 202 patients were administered a questionnaire at the offices of 2 fellowship‐trained shoulder surgeons, 1 located at a tertiary referral center (center A) and 1 in private practice (center B). The questionnaire asked a series of questions about specific factors when choosing an orthopaedic surgeon and the preference for arthroscopic or open surgery. In addition, 7 short‐term and long‐term outcomes were listed, and the patient was asked to choose whether open or arthroscopic surgery would provide the best outcome or whether he or she felt that there was no difference. Results Among patients at center A, 88% would prefer arthroscopy if they were to have shoulder surgery, as would 96% of patients at center B. Among patients at center A, 14% would avoid shoulder surgery if the only option was open surgery, as would 25% at center B. The reputation of the surgeon and institution were the primary factors in choosing a surgeon. Recommendation of a former patient and years of surgeon experience were less important factors for patient selection of a shoulder surgeon. Conclusions The study shows that the vast majority of patients perceive multiple advantages of arthroscopic shoulder surgery despite a lack of published data to support many of these assumptions, particularly with regard to expected functional outcome of arthroscopic versus open shoulder surgery. Clinical Relevance Shoulder surgeons should be aware of these perceptions when discussing treatment options with patients. A continued effort should be made to emphasize known scientific data when considering the relative risks and benefits of arthroscopic and open shoulder surgery.
Arthroscopic Shoulder Synovectomy in Patients With Rheumatoid Arthritis
Sperling, John W. , O’Driscoll, Shawn W. , Cofield, Robert H. , Smith, Adam , Fitzsimmons, James S

Mayo Clinic

Arthroscopy | January 8, 2006 | Volume: 22 | Issue: 1 | Pages: 50-56

10.1016/j.arthro.2005.10.011 | PMID 16399461 Get It

Purpose Currently, there is little information available concerning the results of shoulder synovectomy in patients with rheumatoid arthritis. Furthermore, it remains difficult to assess the success of shoulder synovectomy because of a high association of rotator cuff tears in rheumatoid patients. We hypothesized that synovectomy in patients with a functionally intact rotator cuff would provide durable pain relief. Type of Study Case series. Methods Sixteen shoulders in 13 patients with rheumatoid arthritis were treated with arthroscopic shoulder synovectomy from 1988 to 2002 with a mean follow‐up of 5.5 years. Patients with full‐thickness rotator cuff tears or partial tears that required repair were excluded. Two of the 13 patients had been diagnosed with juvenile rheumatoid arthritis and 11 had adult‐onset disease. The medical records of the patients were reviewed and patients were assessed clinically and by questionnaire to assess pain, satisfaction, range of motion, radiographic outcomes, and occurrence of complications. Results There was an improvement in pain at long‐term follow‐up in 13 of 16 patients ( P < .001). Active shoulder elevation improved from a median of 145° to 160° but was not significant ( P = .14). External rotation improved significantly ( P = .01) from a median of 45° (range, 0° to 90°) to 60° (range, 0° to 100°). According to the Neer rating system, there were 5 excellent, 8 satisfactory, and 3 unsatisfactory results. Seven of 8 shoulders followed‐up radiographically for more than 1 year showed radiographic progression of disease. All 3 patients reporting pain that was no better or worse than before surgery had radiographic arthrosis at last follow‐up with advancing periarticular erosions and reduction of glenoid articular space. Conclusions Arthroscopic synovectomy of the shoulder in patients with rheumatoid arthritis with an intact rotator cuff offers a reliable decrease in pain with less predictable improvements in range of motion. Limitations in predicting final results based on preoperative radiographs should be discussed with patients; those with more advanced radiographic changes may not benefit from the procedure. Level of Evidence Level IV, therapeutic study, case series, no control group.
The “Moving Valgus Stress Test” for Medial Collateral Ligament Tears of the Elbow
O’Driscoll, Shawn W. , Lawton, Richard L., Smith, Adam , Fitzsimmons, James S

Mayo Clinic

The American Journal of Sports Medicine | December 20, 2004 | Volume: 33 | Issue: 2 | Pages: 231-239

10.1177/0363546504267804 | PMID 15701609 Get It

Background The diagnosis of a painful partial tear of the medial collateral ligament in overhead-throwing athletes is challenging, even for experienced elbow surgeons and despite the use of sophisticated imaging techniques. Hypothesis The “moving valgus stress test” is an accurate physical examination technique for diagnosis of medial collateral ligament attenuation in the elbow. Study Design Cohort study (diagnosis); Level of evidence, 2. Methods Twenty-one patients underwent surgical intervention for medial elbow pain due to medial collateral ligament insufficiency or other abnormality of chronic valgus overload, and they were assessed preoperatively with an examination called the moving valgus stress test. To perform the moving valgus stress test, the examiner applies and maintains a constant moderate valgus torque to the fully flexed elbow and then quickly extends the elbow. The test is positive if the medial elbow pain is reproduced at the medial collateral ligament and is at maximum between 120 ° and 70 °. Results The moving valgus stress test was highly sensitive (100%, 17 of 17 patients) and specific (75%, 3 of 4 patients) when compared to assessment of the medial collateral ligament by surgical exploration or arthroscopic valgus stress testing. The mean shear range (ie, the arc within which pain was produced with the moving valgus stress test) was 120 ° to 70 °. The mean angle at which pain was at a maximum was 90 ° of elbow flexion. Conclusions The moving valgus stress test is an accurate physical examination technique that, when performed and interpreted correctly, is highly sensitive for medial elbow pain arising from the medial collateral ligament.
GREATER ARC INJURIES OF THE WRIST TREATED BY INTERNAL AND EXTERNAL FIXATION — SIX CASES WITH MID-TERM FOLLOW-UP
Kohut, Georges , Giudici, M., Büchler, U, Smith, Adam

Mayo Clinic

Hand Surgery | July 27, 2002 | Volume: 01 | Issue: 02 | Pages: 159-166

10.1142/s0218810496000269 Get It

Six cases of greater arc injury, defined as a perilunate dislocation of the carpus with a fracture of at least both the scaphoid and the capitate, were treated by open reposition and both internal and external fixation. Revascularisation of the capitate by implantation of the first dorsal intermetacarpal artery was attempted in three cases. At a mean follow-up of six years and four months, all patients complained of residual pain in the wrist. Carpal mobility and grip strength were reduced, and all patients showed mild or moderate arthritic changes. Progressive cartilage damage over the proximal pole of the capitate seems to be a determining factor in the outcome. Open reposition and both internal and external fixation are recommended in order to possibly diminish the incidence of arthritis and minimise secondary carpal instability.